Stéphane Degove – CEO & CFO


Stéphane has 17 years’ experience in Biotech/Pharma and Strategy. Graduated from ESCP (majoring in Finance), he worked at Sanofi in Finance and was co-founder and CFO of a biotechnology company in cancer and thrombosis, Endotis Pharma. Under his leadership, Endotis Pharma raised € 37 million from international funds and built a portfolio of innovative products developed up to Phase II.

Jean-François Prost, MD – VP R&D and Strategy

2-2-2Jean-François is a Senior Executive of the French and International pharmaceutical industry. Physician specialist in Internal Medicine, Dr. Prost has an experience of 30 years in the industry, having served as Cardiovascular Development Director then Research Director at Servier, R&D Director at Pierre Fabre Medicament and then UCB Pharma, and finally in the last ten years, Scientific and Medical Management at LFB.

Jean-Marc Barret, PhD – Pharmacology Manager

gamamabs1-6Jean-Marc has 20 years’ experience in new entity discovery in oncology, being the former Head of in vitro pharmacology oncology Department of Pierre Fabre.